Back

Find the FamiCord brand in your country

Free guide

Smart Cells free guide

Download

Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

  • Blood cancers such as leukaemia and lymphoma
  • Inherited genetic disorders including thalassemia and sickle cell disease
  • Neurological conditions such as cerebral palsy and brain injury
  • Immune deficiencies and metabolic disorders
  • Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

  • Cerebral Palsy
  • Thalassemia
  • Leukaemia
  • HSV Encephalitis
  • Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

  • Families gain access to 1,000,000+ stored cord blood units across the network
  • Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
  • FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

FamiCord Group releases

Patients

7800+

Expand table
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
7601 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 54,8
7602 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 41,4
7603 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 49,3
7604 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 61,11
7605 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 45,8
7606 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 38,1
7607 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 68,5
7608 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2016 Experimental Therapy Poland 38,4
7609 Cord Tissue Allogeneic – Unrelated Spastic Tetraparesis Orthopedy 2016 Experimental Therapy Poland 28,8
7610 Cord Tissue Allogeneic – Unrelated Spastic Tetraparesis Orthopedy 2016 Experimental Therapy Poland 47,9
7611 Cord Tissue Allogeneic – Unrelated Spastic Tetraparesis Orthopedy 2016 Experimental Therapy Poland 58,4
7612 Cord Tissue Allogeneic – Unrelated Spastic Tetraparesis Orthopedy 2016 Experimental Therapy Poland 18
7613 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 2,4
7614 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 4,8
7615 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 1,5
7616 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 7,4
7617 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 1,3
7618 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 2,11
7619 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 15,9
7620 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 2,11
7621 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2016 Experimental Therapy Poland 4,9
7622 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 33,5
7623 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 22,2
7624 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 28
7625 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 33,11
7626 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 20,7
7627 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 24,5
7628 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 25,6
7629 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 18,8
7630 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 7,4
7631 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 48,3
7632 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 58,1
7633 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 37,11
7634 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 29,7
7635 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 17,9
7636 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2016 Experimental Therapy Poland 44,5
7637 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2016 Experimental Therapy Poland 34,9
7638 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2016 Experimental Therapy Poland 3,3
7639 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2016 Experimental Therapy Poland 34,2
7640 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2016 Experimental Therapy Poland 17,1
7641 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2016 Experimental Therapy Poland 1,1
7642 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2016 Experimental Therapy Poland 64
7643 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2016 Experimental Therapy Poland 62,5
7644 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2016 Experimental Therapy Poland 54,3
7645 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2016 Experimental Therapy Poland 41,8
7646 Cord Tissue Allogeneic – Unrelated Stargardt's Disease Ophthalmology 2016 Experimental Therapy Poland 53
7647 Cord Tissue Allogeneic – Unrelated Stargardt's Disease Ophthalmology 2016 Experimental Therapy Poland 24,5
7648 Cord Tissue Allogeneic – Unrelated Stargardt's Disease Ophthalmology 2016 Experimental Therapy Poland 37,7
7649 Cord Tissue Allogeneic – Unrelated Tetraparesis Orthopedy 2016 Experimental Therapy Poland 27,9
7650 Cord Tissue Allogeneic – Unrelated Tetraparesis Orthopedy 2016 Experimental Therapy Poland 27,2
7651 Cord Tissue Allogeneic – Unrelated Traumatic Brain Injury Neurology 2016 Experimental Therapy Poland 54,9
7652 Cord Blood Allogeneic – Related Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Hungary 7
7653 Cord Blood Allogeneic – Unrelated Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 6
7654 Cord Blood Autologous Autism Neurology 2016 Experimental Therapy Poland 6
7655 Cord Blood Autologous Brain Damage Neurology 2016 Experimental Therapy Germany 1
7656 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2016 Experimental Therapy UK 6
7657 Cord Blood Allogeneic – Related Hermansky-Pudlak Syndrome Type 2 Hematology 2016 Standard Therapy Turkey 6
7658 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2016 Standard Therapy Germany 4,3
7659 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 38
7660 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 38
7661 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 66
7662 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 32
7663 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 62
7664 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 72
7665 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia, Minimal Residual Disease Hematology 2016 Standard Therapy Poland 50
7666 Bone Marrow Family Allogeneic Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 18
7667 Bone Marrow Family Allogeneic Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 32
7668 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 59
7669 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 67
7670 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 62
7671 Bone Marrow Family Allogeneic No Data no data 2016 Standard Therapy Poland 59
7672 Bone Marrow Family Allogeneic No Data no data 2016 Standard Therapy Poland 4
7673 Bone Marrow Family Allogeneic Plasma Cell Disorder Hematology 2016 Standard Therapy Poland 54
7674 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 9
7675 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 6
7676 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 14
7677 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 7
7678 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 11
7679 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 18
7680 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 5
7681 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 25
7682 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 1
7683 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 5
7684 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 15
7685 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 6
7686 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 64
7687 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 55
7688 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 64
7689 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 12
7690 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 67
7691 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 29
7692 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 33
7693 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 39
7694 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 9
7695 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 45
7696 Bone Marrow Allogeneic Anemia Hematology 2016 Standard Therapy Poland 16
7697 Bone Marrow Allogeneic Anemia Hematology 2016 Standard Therapy Poland 5
7698 Bone Marrow Allogeneic Aplastic Anemia Hematology 2016 Standard Therapy Poland 20
7699 Bone Marrow Allogeneic Bilineal Leukemia – Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia Hematology 2016 Standard Therapy Poland 27
7700 Bone Marrow Allogeneic Diamond Blackfan Anemia Hematology 2016 Standard Therapy Poland 2
Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

Icon

100% infusion success rate

For samples released for transplant.

Icon

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

Icon

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

24

Expand table
Sample release date Medical condition Recipient relationship Age of the recipient Unit volume Medical center Country
2005.11 Thalassemia Allogeneic (Sibling) 4 Years 144ml Mount Vernon Hospital Singapore
2005.11 Leukaemia Allogeneic (Sibling) Restricted Restricted Stem Cells and Immunology Department, Birmingham UK
2007.02 Thalassemia Allogeneic (Sibling) 7 Years 76ml Kinderlink der Tu Munchen Germany
2009.08 Cerebral Palsy Autologous (Self) 3 Years 51ml Duke University, North Carolina USA
2010.01 Cerebral Palsy Autologous (Self) 3 Years 81ml Duke University, North Carolina USA
2013.10 Thalassemia Allogeneic (Sibling) 5 Years 58ml Catherine Lewis Centre, Hammersmith UK
2014.01 Leukaemia Allogeneic (Sibling) 4 Years 71ml Medizinische Hochschule, Hanover Germany
2014.05 Cerebral Palsy Autologous (Self) 1 year 68ml Duke University, North Carolina USA
2014.06 HSV Encephalitis & NMDA Receptor Antibody Virus Autologous (Self) 2 Years 57ml Duke University, North Carolina USA
2014.08 Hypoxic Ischemic Encephalopathy (HIE) Autologous (Self) 3 Months 39ml Duke University, North Carolina USA
2015.02 Hypoxic Ischemic Encephalopathy (HIE) Autologous (Self) 6 Months 53ml Duke University, North Carolina USA
2015.03 Severe Combined Immune Deficiency Autologous (Self) 3 Months 74ml Duke University, North Carolina USA
2015.03 Sickle Cell Disease Allogeneic (Sibling) 2 .5 Years 57ml BLK Hospital, New Delhi India
2015.11 Thalassemia Allogeneic (Sibling) 12 Years 87ml Children’s Hospital of Pittsburgh of UPMC USA
2016.03 Cerebral Palsy Allogeneic (Sibling) 6 Years 101ml Duke University, North Carolina USA
2017.04 Lymphoblastic Leukaemia (^1) N/A (Identical twin girls) Restricted 125ml Bambin Gesu Childrens’ Hospital, Rome Italy
2017.06 Cerebral Palsy Autologous (Self) 7 Years 82ml Duke University, North Carolina USA
2017.06 Cerebral Palsy Autologous (Self) 3.4 Years 132ml Duke University, North Carolina USA
2018.03 Autism Autologous (Self) 5.4 Years 73ml Duke University, North Carolina USA
2018.03 Cerebral Palsy Autologous (Self) 3.4 years 132ml Duke University, North Carolina USA
2019.06 Cerebral Palsy Allogeneic (Sibling) 3 Years 104ml Duke University, North Carolina USA
2022.02 Cerebral Palsy Allogeneic (Sibling) 11 Years 185ml Duke University, North Carolina USA
2023.08 Cerebral Palsy Allogeneic (Sibling) 3 Years 46ml Duke University, North Carolina USA
2024.01 Thalassaemia Allogeneic (Sibling) 8 Years 45ml Cincinnati Children’s Hospital Medical Center USA
Expand table
Icon

Ready to get started or need more information?